Key opinion leaders explore financial considerations associated with switching to biosimilar products.
This is a video synopsis/summary of a panel discussion involving Ryan Haumschild, PharmD, MS, MBA; Alice B. Gottlieb, MD, PhD; Bincy Abraham, MD, MS; Jamie T. Brogan, APRN; and Vibeke Strand, MD.
Ryan Haumschild asks Vibeke Strand to discuss biosimilar cost savings and who is driving and benefiting from them.
Strand says patients should benefit, but it is unclear whether they do, given the health care system maze involving pharmacy benefit managers (PBMs) that determine payer coverage. Providers have little insight into PBM processes and formulary decision-making. Limitations exist even with Medicare and Medicaid. With multiple adalimumab (Humira) biosimilars at varying discounts, it is unknown how to translate that into patient cost savings at the point of prescribing. Greater transparency around cost impacts for patients is needed.
Haumschild agrees the value proposition around cost is opaque for patients. Although payers and providers in value-based contracts may benefit from lower expenses, it is difficult to demonstrate financial benefits directly reaching patients facing financial toxicity and adherence challenges. More clarity around patient costs is needed.
Video synopsis is AI-generated and reviewed by AJMCÒ editorial staff.
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
2 Commerce Drive
Cranbury, NJ 08512